Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LDHA | P00338 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1638842 | 0.93 | MEN1 (0.45) | MEN1KMT2ALDHAMAPTLMNA | |
| SCHEMBL6321010 | 0.91 | LDHA (0.48) | MEN1KMT2ALDHAMAPTLMNA | |
| SCHEMBL6255843 | 0.89 | PPARA (0.49) | MEN1KMT2ALDHAMAPTLMNA | |
| SCHEMBL24419014 | 0.86 | KMT2A (0.52) | MEN1KMT2ALDHAMAPTLMNA | |
| SCHEMBL16192959 | 0.84 | F2 (0.45) | MEN1KMT2ARAB9AMGLLRXRA | |
| SCHEMBL17637680 | 0.84 | TP53 (0.52) | MEN1KMT2ALMNAMAPK1RAB9A | |
| SCHEMBL11013322 | 0.82 | LMNA (0.42) | MEN1KMT2ALDHAMAPTLMNA | |
| SCHEMBL3504737 | 0.82 | LDHA (0.54) | MEN1KMT2ALDHAMAPTLMNA | |
| SCHEMBL9671509 | 0.82 | LDHA (0.48) | MEN1KMT2ALDHAMAPTLMNA | |
| SCHEMBL22228973 | 0.81 | MGLL (0.41) | MEN1KMT2ALDHAMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572728-B1 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | MOUNTAIN VIEW PHARMACEUTICALS (US) | 2014-06-25 | — | — | EP | claimed |
| US-20120114742-A1 | Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2012-05-10 | — | — | US | claimed |
| US-8129330-B2 | Complex of polyoxyethylene glycol with active material | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2012-03-06 | — | — | US | claimed |
| EP-1560871-B1 | METHOD FOR MAKING COPOLYCARBONATES | GEN ELECTRIC (US) | 2006-10-11 | — | — | EP | claimed |
| JP-2006510601-A | — | — | 2006-03-30 | — | — | JP | claimed |
| EP-1572728-A2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | Mountain View Pharmaceuticals, Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| EP-1560871-A1 | METHOD FOR MAKING COPOLYCARBONATES | GENERAL ELECTRIC COMPANY (US) | 2005-08-10 | — | — | EP | claimed |
| EP-1421175-A4 | POLYMER STABILIZED PROTEINASES | MOUNTAIN VIEW PHARMACEUTICALS (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1421175-A2 | POLYMER STABILIZED PROTEINASES | Mountain View Pharmaceuticals, Inc. (US) | 2004-05-26 | — | — | EP | claimed |
| WO-2004041907-A1 | METHOD FOR MAKING COPOLYCARBONATES | GENERAL ELECTRIC COMPANY (US) | 2004-05-21 | — | — | WO | claimed |
| WO-2004030617-A2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2004-04-15 | — | — | WO | claimed |
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-6657038-B1 | Melt condensation copolymerization of dihydroxyaromatic compounds and diphenyl carbonate derivative in presence of metal hydroxide and quaternary phosphonium salt | GENERAL ELECTRIC COMPANY | 2003-12-02 | — | — | US | claimed |
| US-20030012777-A1 | Polymer conjugates of proteinases | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2003-01-16 | — | — | US | claimed |
| WO-2003002716-A2 | POLYMER STABILIZED PROTEINASES | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| CN-122095024-A | Flame-retardant aromatic polycarbonate resin composition and molded article thereof | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026100296-A1 | FLAME-RETARDANT AROMATIC POLYCARBONATE RESIN MASTER BATCH AND METHOD FOR MANUFACTURING SAME | 信越化学工業株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-3945967-A | ALKYL PHOSPHITE, EPOXY COMPOUND | GENERAL ELECTRIC COMPANY (US) | 1976-03-23 | — | — | US | disclosed |
| US-3933730-A | POLYDIMETHYLSILOXANE GUM, DIVIDED SILICA | GENERAL ELECTRIC COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | MEN1 1245/4885KMT2A 2567/4885LDHA 2217/4885 |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | MEN1 1245/4885KMT2A 2567/4885LDHA 2217/4885 |
| US-20120114742-A1 | Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof | CD14, HLA-C, HLA-A | MEN1 1245/4885KMT2A 2567/4885LDHA 2217/4885 |
| US-20030012777-A1 | Polymer conjugates of proteinases | PRNP, PRSS3, PRSS1 | MEN1 4007/4885KMT2A 2115/4885LDHA 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.